8-K
filed February 2, 2024, 6:59 PM ET
CIK 0001402479
other material
confidence high
sentiment negative
materiality 1.00
MedAvail Holdings, Inc.: auditor change — MedAvail files Chapter 7 bankruptcy; board, execs, auditor resign
MedAvail Holdings, Inc.
- Filed voluntary Chapter 7 petition on Feb 2, 2024; assets to be liquidated by court-appointed trustee.
- SingerLewak LLP resigned as independent auditor effective immediately prior to filing; no audit report had been issued.
- All board members (Doerr, Faulkner, Johnson, Kramer, McGraw, Stettin) resigned effective Feb 2.
- CEO Mark Doerr and CFO Ramona Seabaugh terminated effective Feb 2 due to bankruptcy.
Key facts
Extracted from this filing and checked against the source text.
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
SingerLewak LLP resigned as auditor of MedAvail Holdings, Inc..
- Action
- resignation
- Auditor
- SingerLewak LLP
Exact text from the filing
On February 1, 2024, SingerLewak LLP, the Company’s independent registered public accounting firm, informed the Company of its decision to resign as auditors of the Company, effective immediately prior to the filing of the Petition. From the date of its engagement on June 14, 2023 through the date of its resignation, SingerLewak did not render an audit report on the Company’s financial statements for any period.
View on SEC.gov
Distress & Bankruptcy
SEC 8-K Item 1.03
confidence 0.9
MedAvail Holdings, Inc. entered chapter 7 in United States Bankruptcy Court for the District of Delaware (petition 2024-02-02).
- Proceeding
- chapter 7
- Court
- United States Bankruptcy Court for the District of Delaware
- Petition
- 2024-02-02
Exact text from the filing
MedAvail Holdings, Inc., a Delaware corporation (the “ Company ”), filed a voluntary petition for relief (the “ Petition ”) under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §§ 101 et seq. (the “ Code ”) in the United States Bankruptcy Court for the District of Delaware (the “ Bankruptcy Court ”) on February 2, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Laurie McGraw resigned as Director at MedAvail Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Glen Stettin resigned as Director at MedAvail Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mark Doerr was terminated as President and Chief Executive Officer at MedAvail Holdings, Inc..
- Action
- terminated
- Role
- President and Chief Executive Officer
Exact text from the filing
The Company terminated the employment of Mark Doerr, the Company’s President and Chief Executive Officer, and Ramona Seabaugh, the Company’s Chief Financial Officer, Treasurer and Secretary, effective on February 2, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paul Johnson resigned as Director at MedAvail Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mark Doerr resigned as Director at MedAvail Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert Faulkner resigned as Director at MedAvail Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Kramer resigned as Director at MedAvail Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ramona Seabaugh was terminated as Chief Financial Officer, Treasurer and Secretary at MedAvail Holdings, Inc..
- Action
- terminated
- Role
- Chief Financial Officer, Treasurer and Secretary
Exact text from the filing
The Company terminated the employment of Mark Doerr, the Company’s President and Chief Executive Officer, and Ramona Seabaugh, the Company’s Chief Financial Officer, Treasurer and Secretary, effective on February 2, 2024
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.